Skip to main content

Drug Interactions between lutetium lu 177 dotatate and Mycapssa

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

octreotide lutetium Lu 177 dotatate

Applies to: Mycapssa (octreotide) and lutetium lu 177 dotatate

Medications like octreotide can reduce the effectiveness of lutetium Lu 177 dotatate depending on when they are administered relative to the dose of lutetium Lu 177 dotatate. In general, long-acting formulations of these medications (usually those given by intramuscular injection) should be discontinued for at least 4 weeks and short-acting formulations should be discontinued for at least 24 hours prior to each dose of lutetium Lu 177 dotatate. You may use octreotide following an infusion of lutetium Lu 177 dotatate, but it is important to adhere to the dosing schedules exactly as prescribed so as to minimize the risk for interaction. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

octreotide food

Applies to: Mycapssa (octreotide)

Octreotide may affect the absorption of dietary nutrients and medications that you take by mouth, including some vitamin and nutritional supplements. Contact your doctor if your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer